Effect of Aerobic Exercise and Caloric Restriction on Serum Adropin Levels and HOMA-IR in Obese Sedentary Women

Document Type : Research Paper

Authors

1 Associate Professor of Sport Physiology, University of Tehran

2 Ph. D. Student in Sport Physiology, University of Tehran

3 Professor of Sport Physiology, University of Tehran

Abstract

The aim of this study was to compare the effects of aerobic exercise and caloric restriction on serum adropin levels, insulin resistance index (HOMA-IR) and anthropometric parameters in obese sedentary women. For this purpose, 30 obese sedentary women were recruited (Mean age: 40.2±5.4 year; weight: 77.9±7.1kg). Subjects randomly were divided into three groups for 16 weeks follow up: caloric restriction (experimental group 1 or CR), aerobic exercise with caloric restriction (experimental group 2 or EX+CR) and control group. In CR group, subjects follow a diet with 25% caloric restriction. Subjects in CR+EX group used a training program including aerobic exercise and running on treadmill for 66.85±5.34 minutes; 3 times a week and received a diet with 50% caloric restriction of CR group (12.5% caloric restriction+12.5% increase in energy expenditure). Before and after 16 weeks, blood sampling for measurement of serum adropin was carried out. Data were analyzed by paired sample t-test and one-way ANOVA at significant level of P

Keywords

Main Subjects

References

1. Aydin S. Three new players in energy regulation: Preptin, adropin and irisin. Peptides. 2014; 56: 94–110.
2. Van Gaal L F, Mertens I L, De Block C E. Mechanisms linking obesity with cardiovascular disease. Nature. 2006; 444‌(7121): 875-80.
3. Aydin S, Kuloglu T, Nesimi M, Yilmaz M, Kalayci M, Sahin I, et al. Expression of adropin in rat brain, cerebellum, kidneys, heart, liver, and pancreas in streptozotocin-induced diabetes. Mol Cell Biochem. 2013; 380‌(1): 73-81.
4. Gao S, McMillan R P, Jacas J, Zhu Q, Li X, Kumar G K, et al. Regulation of substrate oxidation preferences in muscle by the Peptide Hormone Adropin. Diabetes. 2014; 63(10): 324-52.
5. Kumar K G, Trevaskis J L, Lam D D, Sutton G M, Koza R A, Chouljenko V N, et al. Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell Metab. 2008; 8: 468–81.
6. Kumar K G, Zhang J, Gao S, Rossi J, McGuinness O P, Halem H H, et al. Adropin deficiency is associated with increased adiposity and insulin resistance. Obesity (Silver Spring). 2012; 20: 1394–402.
7. Butler A A, Tam C S, Stanhope K L, Wolfe B M, Ali M R, O’Keeffe M, et al. Low circulating adropin concentrations with obesity and aging correlate with risk factors for metabolic disease and increase after gastric bypass surgery in humans. J Clin Endocrinol Metab. 2012; 97: 3783–91.
8. Sayın O, Tokgöz Y, Arslan N. Investigation of adropin and leptin levels in pediatric obesity-related nonalcoholic fatty liver disease. J Pediatr Endocrinol Metab. 2014; 27(5-6): 479-84.
9. Lefevre M, Redmana L M, Heilbronn L K. Caloric restriction alone and with exercise improves CVD risk in healthy non-obese individuals. Atherosclerosis. 2009; 203: 206–13.
10. Douglas CC, Lawrence JC, Bush NC, Oster RA, Gower BA, Darnell BE, et al. Ability of the Harris Benedict formula to predict energy requirements differs with weight history and ethnicity. Nutr Res. 2007; 27(4):194-199.
11. Mallinson R J, Williams N I, Olmsted M P, Scheid J L, Riddle E S. A case report of recovery of menstrual function following a nutritional intervention in two exercising women with amenorrhea of varying duration. J Int Soc Sports Nutr. 2013; 2: 10-34.
12. Altincik A, Sayin O. Evaluation of the relationship between serum adropin levels and blood pressure in obese children. J Pediatr Endocrinol Metab. 2015, 28(9-10): 1095-1100.
13. Kwak M S, Kim D, Chung G E, Kim W, Kim Y J, Yoon J H. Role of physical activity in nonalcoholic fatty liver disease in terms of visceral obesity and insulin resistance. Liver Int. 2015; 35(3): 944–52.
14. Gao S, McMillan R P, Zhu Q, Lopaschuk G D, Bulter A, Hulver M W. Therapeutic effects of adropin on glucose tolerance and substrate utilization in diet-induced obese mice with insulin resistance. Mol Metab. 2015; 4(4): 310-24.
15. Wong C M, Wang Y, Lee J T, Wu D, Xu A, Ling K S. Adropin is a brain membrane-bound protein regulating physical activity via the NB-3/ Notch signaling pathway in Mice. J Biol Chem. 2014; 289: 25976-86.
16. Wu L, Fang J, Chen L, Zhao Z, Luo Y, Lin C, et al. Low serum adropin is associated with coronary atherosclerosis in type 2 diabetic and non-diabetic patients. Clin Chem Lab Med. 2014; 52(5): 751–8.
Sport Physiology
Volume 9, Issue 34 - Serial Number 34
Summer 2017
July 2017
Pages 49-62

Files

History

  • Receive Date: 22 August 2015
  • Revise Date: 02 March 2016
  • Accept Date: 03 April 2016

Share

How to cite

Statistics